Vascular Endothelial Growth Factor B and Its Signaling

作者: Nathaniel Lal , Karanjit Puri , Brian Rodrigues

DOI: 10.3389/FCVM.2018.00039

关键词:

摘要: In diabetes, compromised glucose utilization leads the heart to use FA almost exclusively for ATP generation. Chronically, this adaptation unfortunately conversion of potentially toxic metabolites. Paired with increased formation reactive oxygen species related excessive mitochondrial oxidation FA, can provoke cardiac cell death. To protect against demise, intrinsic mechanisms must be available heart. Vascular endothelial growth factor B (VEGFB) may one that plays an important role in protecting failure. As a member VEGF family, initial studies VEGFB focused on its angiogenesis. Surprisingly, does not appear play direct angiogenesis under normal conditions or even when overexpressed, but has been implicated influencing vascular indirectly by affecting VEGFA action. Intriguingly, also shown alter gene expression proteins involved metabolism and promote survival. Conversely, multiple models failure, including diabetic cardiomyopathy, have indicated significant drop VEGFB. review, we will discuss biology VEGFB, relationship cardiomyopathy.

参考文章(79)
Nektaria Simiantonaki, Charles James Kirkpatrick, Caren Jayasinghe, VEGF-B expression in colorectal carcinomas and its relevance for tumor progression. Histology and Histopathology. ,vol. 28, pp. 647- 653 ,(2013) , 10.14670/HH-28.647
Eugenio Picano, Diabetic cardiomyopathy. the importance of being earliest. Journal of the American College of Cardiology. ,vol. 42, pp. 454- 457 ,(2003) , 10.1016/S0735-1097(03)00647-8
Xiaojuan Yang, Yin Zhang, Kayoko Hosaka, Patrik Andersson, Jian Wang, Fredrik Tholander, Ziquan Cao, Hiromasa Morikawa, Jesper Tegnér, Yunlong Yang, Hideki Iwamoto, Sharon Lim, Yihai Cao, VEGF-B promotes cancer metastasis through a VEGF- A-independent mechanism and serves as a marker of poor prognosis for cancer patients Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 201503500- ,(2015) , 10.1073/PNAS.1503500112
Oktay Tacar, Pornsak Sriamornsak, Crispin R. Dass, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems Journal of Pharmacy and Pharmacology. ,vol. 65, pp. 157- 170 ,(2012) , 10.1111/J.2042-7158.2012.01567.X
Vivienne C. Ho, Guo-Hua Fong, Vasculogenesis and Angiogenesis in VEGF Receptor-1 Deficient Mice Methods of Molecular Biology. ,vol. 1332, pp. 161- 176 ,(2015) , 10.1007/978-1-4939-2917-7_12
Gerald Kessler, Jacob Friedman, None, Metabolism of Fatty Acids and Glucose Circulation. ,vol. 98, pp. 1351- ,(1998) , 10.1161/CIRC.98.13.1350/A
Mikio Momoeda, Hiroaki Mizukami, Hiroyuki Yoshikawa, Akihiro Kume, Yuji Taketani, Yoko Hasumi, Keiya Ozawa, Masabumi Shibuya, Masashi Urabe, Takashi Tsuruo, Takahiro Kohno, Koichi Takeuchi, Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer. Cancer Research. ,vol. 62, pp. 2019- 2023 ,(2002)
Peter Carmeliet, Lieve Moons, Aernout Luttun, Valeria Vincenti, Veerle Compernolle, Maria De Mol, Yan Wu, Françoise Bono, Laetitia Devy, Heike Beck, Dimitri Scholz, Till Acker, Tina DiPalma, Mieke Dewerchin, Agnes Noel, Ingeborg Stalmans, Adriano Barra, Sylvia Blacher, Thierry Vandendriessche, Annica Ponten, Ulf Eriksson, Karl H. Plate, Jean-Michel Foidart, Wolfgang Schaper, D. Stephen Charnock-Jones, Daniel J. Hicklin, Jean-Marc Herbert, Désiré Collen, M. Graziella Persico, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nature Medicine. ,vol. 7, pp. 575- 583 ,(2001) , 10.1038/87904
Ryan Lee, Tien Y. Wong, Charumathi Sabanayagam, Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss Eye and vision (London, England). ,vol. 2, pp. 17- 17 ,(2015) , 10.1186/S40662-015-0026-2
Mitsuro Kanda, Shuji Nomoto, Yoko Nishikawa, Hiroaki Sugimoto, Naohito Kanazumi, Shin Takeda, Akimasa Nakao, Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. Journal of Surgical Oncology. ,vol. 98, pp. 190- 196 ,(2008) , 10.1002/JSO.21095